Business Context and Reporting Period
This Form 8-K, filed on February 27, 2025, by Synopsys, Inc. (SNPS), reports on the ongoing proposed merger with ANSYS, Inc. The filing serves to update investors with audited financial statements for ANSYS and unaudited pro forma combined financial statements for the merged entity. The transaction, originally announced on January 15, 2024, involves a merger subsidiary of Synopsys merging with ANSYS, with ANSYS surviving as a wholly-owned subsidiary of Synopsys.
Key Financial Metrics and Pro Forma Information
The filing does not contain Synopsys' standalone current period revenue, profit, or cash flow figures, as it explicitly states it does not modify or update Synopsys' previously filed 10-K or 10-Q reports. Instead, it provides the following data points:
- ANSYS Audited Data: Includes audited consolidated balance sheets as of December 31, 2024, and 2023, and statements of income, comprehensive income, equity, and cash flows for the three years ended December 31, 2024 (detailed in Exhibit 99.1).
- Pro Forma Combined Data: Includes unaudited pro forma condensed combined balance sheets as of January 31, 2025, and statements of operations for the year ended October 31, 2024, and the three months ended January 31, 2025 (detailed in Exhibit 99.2).
- Limitations: The pro forma financial information is prepared for informational purposes only, based on specific assumptions, and does not reflect actual future results or financial condition.
Material Changes and Updates
This filing supersedes the unaudited pro forma financial information previously disclosed in Amendment No. 1 to Form S-4 filed on April 11, 2024. The primary material update is the inclusion of ANSYS' audited financial statements for the year ended December 31, 2024, which were previously disclosed by ANSYS in its own 10-K. No specific numerical changes to Synopsys' standalone financial metrics are reported in this document.
Guidance, Outlook, Risks, and Contingencies
The filing contains extensive cautionary statements regarding forward-looking information related to the merger. Key risks and contingencies identified include:
- Regulatory Approval: The transaction is subject to governmental and regulatory approvals, which may be delayed, denied, or imposed with conditions that adversely affect the combined company.
- Financing and Debt: Risks regarding access to financing to consummate the transaction and the ability to manage additional debt and covenants post-merger.
- Integration Challenges: Uncertainties regarding the successful integration of operations, product lines, and the retention of key personnel.
- Market and Macroeconomic Factors: Risks related to the semiconductor and electronics industries, including competition, customer consolidation, and geopolitical factors such as export restrictions.
- Legal Proceedings: Potential legal actions related to the Merger Agreement.
Management emphasizes that forward-looking statements are not guarantees and that actual results may differ materially due to these uncertainties.
Investor Verification Checklist
- Review Exhibit 99.1 for ANSYS' audited financial statements to understand the target's standalone financial health.
- Examine Exhibit 99.2 for the unaudited pro forma combined financial statements to assess the projected financial impact of the merger.
- Verify the status of regulatory approvals required for the merger, as this is a primary condition for consummation.
- Consult the Proxy Statement/Prospectus referenced in the filing for a comprehensive list of risk factors and detailed transaction terms.
- Check Synopsys' most recent Form 10-Q (for the quarter ended January 31, 2025) for the company's actual standalone operating results, as this 8-K does not provide them.